← All trials
NCT04950842
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 15, 2020
- Primary completion
- Feb 28, 2025
- Completion date
- Feb 28, 2025
- First posted
- Jul 6, 2021
- Last posted
- Sep 17, 2021
- Enrollment
- 10
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Juntendo UniversityLead sponsor
- Juntendo UniversityCollaborator
- Juntendo UniversityStudy chair
- Juntendo UniversityReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.